AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Multiply Labs, Inc. announced it raised $25 Million in an amended filing from an offering of $25 Million

Apr 21, 2021•over 4 years ago

Amount Raised

$25 Million

San FranciscoInformation Technology

Company News

(9 articles)

Tue, 24 Sep 2024 07:00:00 GMT

Legend Biotech inks deal for 'priority access' to Multiply Labs' robotic cell therapy production tech - Fierce Pharma

Tue, 23 Apr 2024 07:00:00 GMT

Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing - PR Newswire

Tue, 24 Sep 2024 07:00:00 GMT

Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing with Legend Biotech - Yahoo Finance

Thu, 05 May 2022 07:00:00 GMT

Multiply Labs Adds Thermo Fisher Scientific and Charles River Laboratories to Its Robotic Manufacturing Consortium - Business Wire

Thu, 15 Apr 2021 07:00:00 GMT

Multiply Labs raises $20M for robotic pharma manufacturing - The Robot Report

Wed, 23 Feb 2022 08:00:00 GMT

Automating cell therapy - MIT Technology Review

Wed, 11 Oct 2023 07:00:00 GMT

Multiply Labs Collaborates with Industry Leaders University of California San Francisco, Cytiva, Thermo Fisher Scientific and Charles River to Deliver a Successful Proof-of-Concept of Robotic Cell Therapy Manufacturing - Business Wire

Wed, 14 Apr 2021 07:00:00 GMT

Multiply Labs Announces $20 Million Series A to Pioneer Robotic Manufacturing of Individualized Drugs - Business Wire

Mon, 12 Feb 2024 08:00:00 GMT

Multiply Labs and Thermo Fisher Scientific Expand Partnership to Automate Cell Expansion and Separation in Cell Therapy Manufacturing - Business Wire

FundzWatch™ Score

Medium Activity

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech